Chronic Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Kidney Disease stocks.

Chronic Kidney Disease Stocks Recent News

Date Stock Title
Oct 4 SNY Market Chatter: Sanofi Healthcare Suitors Revise Offers Amid Talc Liability Concerns
Oct 4 SNY Sanofi consumer health unit bidders revising offers over talc powder concerns - report
Oct 4 AZN Pharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
Oct 4 SNY Pharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
Oct 4 SNY Sanofi Healthcare Bidders Revising Offers Over Talc Concerns
Oct 4 SNY GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Oct 4 SNY Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply
Oct 4 SNY GSK, Sanofi, CSL said to win $72M U.S. bird flu vaccine contract
Oct 4 SNY Sanofi Sells Global Rights To Rare Autoimmune Drug Enjaymo For $825M Upfront To Italian Firm Recordati
Oct 4 AZN AbbVie Cuts 2024 Earnings Guidance to Include Acquisition Costs
Oct 4 SNY Sanofi inks $1B deal to sell autoimmune disorder therapy
Oct 4 SNY Sanofi’s rare disease drug finds yet another home
Oct 4 AZN Thermo Fisher plant making Astra/ Sanofi RSV drug reportedly breached FDA rules
Oct 4 SNY Thermo Fisher plant making Astra/ Sanofi RSV drug reportedly breached FDA rules
Oct 4 SNY Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Oct 4 SNY Texas sues major PBMs, pharma companies over high insulin prices
Oct 4 AZN How to minimise a capital gains tax impact on your investments
Oct 3 AZN AstraZeneca Seeks Expanded Use For Blood Cancer Drug Calquence, FDA Grants Priority Review
Oct 3 AZN AstraZeneca's Calquence sNDA Gets FDA Priority Tag for Expanded Use
Oct 3 AZN AstraZeneca supplemental NDA for Calquence accepted by FDA
Chronic Kidney Disease

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

Browse All Tags